Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-κB activation early during virus infection. We also identify that the SARS-CoV-2 viral proteins NSP1 and NSP13 can block interferon activation via distinct mechanisms. NSP1 antagonizes interferon signaling by suppressing host mRNA translation, while NSP13 downregulates interferon and NF-κB promoter signaling by limiting TBK1 and IRF3 activation, as phospho-TBK1 and phospho-IRF3 protein levels are reduced with increasing levels of NSP13 protein expression. NSP13 can also reduce NF-κB activation by both limiting NF-κB phosphorylation and nuclear translocation. Last, we also show that NSP13 binds to TBK1 and downregulates IFIT1 protein expression. Collectively, these data illustrate that SARS-CoV-2 bypasses multiple innate immune activation pathways through distinct mechanisms.
【초록키워드】 severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, coronavirus, translation, interferon, Viral proteins, molecular mechanism, severe acute respiratory syndrome Coronavirus, global pandemic, nsp13, Disease progression, immune evasion, pathway, nsp1, IRF3, interferon signaling, mechanisms, virus infection, respiratory, SARS-CoV-2 pathogenesis, NF-κB, acute respiratory syndrome, Activation, Viral protein, acute respiratory syndrome coronavirus, These data, TBK1, IFIT1, molecular mechanisms, multiple innate immune activation pathways, NF-κB activation, NF-κB phosphorylation, NF-κB promoter signaling, nuclear translocation, phospho-TBK1, protein expression, protein level, infecting, innate immune activation, host mRNA, bind, identify, caused, reduced, reduce, downregulate, bypasse, Last, phospho-IRF3, the SARS-CoV-2, 【제목키워드】 Protein, mechanism, Activation, SARS-CoV-2 viral, inhibit,